title: Hearing impairment during deferoxamine therapy for thalassemia major.
authors.forename: F
authors.initials: F
authors.lastname: Argiolu
authors.forename: G
authors.initials: G
authors.lastname: Diana
authors.forename: A
authors.initials: A
authors.lastname: Avignone
authors.forename: A
authors.initials: A
authors.lastname: Cao
authors.forename: S
authors.initials: S
authors.lastname: Di Ninni
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D003676:Deferoxamine / Q000009:adverse effects*; D006319:Hearing Loss, Sensorineural / Q000139:chemically induced*; D006801:Humans; D013789:Thalassemia / Q000150:complications* / Q000188:drug therapy
chemical_list: D003676:Deferoxamine